Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
SAN FRANCISCO–(BUSINESS WIRE)– Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing round led by Khosla Ventures, with participation from Y Combinator. Read More
Gravitas Medical Inc. Announces SECOND FDA Breakthrough Device Designation for its Entarik System; Pediatric Patients to Benefit from Enteral Nutrition Innovation!
Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik’s revolutionary technology. SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ — Gravitas Medical Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has... Read More →
Xpan secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the United States
The XpanTM Universal Trocar System is a first of its kind, radially expanding trocar that can be tailored by surgeons during laparoscopic procedures to accommodate 3 mm up to 12 mm instruments TORONTO–(BUSINESS WIRE)–Xpan Inc., a medical device company focused... Read More →
Vivante’s GIThrive Becomes First Digestive Health Platform Selected for The Evernorth Digital Health Formulary
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) — Digital digestive health solution provider Vivante Health today announced the addition of its GIThrive solution to the Evernorth Digital Health Formulary, which connects employers, insurers, and customers with innovative, affordable, and evidence-based care... Read More →
Movn Health Selected as Winner of Point32Health’s Second Innovation Challenge
CANTON, Mass., Dec. 12, 2023 /PRNewswire/ — Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced Movn Health as the winner of its second annual Innovation Challenge. Based in Irvine, California, Movn Health is... Read More →
OtoNexus Medical Technologies Selected for Elite FDA STeP Program
FDA STeP Program awarded to OtoNexus Medical Technologies for ultrasound platform technology that evaluates middle ear infections. SEATTLE, Dec. 6, 2023 /PRNewswire/ — OtoNexus Medical Technologies, the developer of the Novoscope ultrasound otoscope for immediate and automatic differentiation of bacterial... Read More →
Bone Health Technologies Earns 4th Patent for Osteoboost Device
Recognizes the invention as a wearable apparatus focused on the treatment or prevention of osteopenia or osteoporosis. Bone Health Technologies (BHT), an innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization... Read More →
TIMING to demonstrate reduced AICD and improved motility of hydroporated cells featuring CellChorus and Indee Labs
HOUSTON, Texas — December 5, 2023 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how cells perform and interact over time, announced the publication by Indee Labs of a summary of how the CellChorus® TIMING™ platform... Read More →
Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure
Innovating a new era in endoscopic obesity treatment with Nitinotes’ EndoZip(TM) System, a revolutionary, fully automated suturing device. Nitinotes, developers of EndoZip™, a revolutionary, fully automated suturing device, announced the appointment of Mr. John Barr as the new Chairman of... Read More →
Bright Uro Announces $23M Series A Funding Round Led by Laborie – Expands Senior Leadership Team to Accelerate Next Phase of Commercialization
Company Names Chief Product Development Officer and Chief Commercial Officer as Glean continues to progress to regulatory clearance IRVINE, Calif.–(BUSINESS WIRE)–Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations... Read More →